Beckman Research Departments & Centers
The result? A history of breakthrough innovations helping patients here and around the world, with even more to come in the years ahead.
Uncovering the basic mechanisms of genetics, gene expression and function, signaling pathways, mutagenesis, DNA repair and epigenetics as they relate to the development and progression of cancer.
Cancer Genetics and Epigenetics
Studies here are focused on discovering the fundamental mechanisms of DNA replication and DNA damage repair during cell growth.
Center for Cancer and Aging
The Center for Cancer and Aging unites investigators from all cancer disciplines to study biology, treatment and survivorship issues that face older adults with cancer.
Clinical Diabetes, Endocrinology & Metabolism
For patients with diabetes and other endocrine or metabolic disorders, therapy options and management approaches for diabetes and endocrinology are more plentiful than ever. Treatment is tailored to the individual, with the type of disease and its severity determining the optimal course of treatment.
Developmental and Stem Cell Biology
Offering a multidisciplinary research and training environment in neurobiology with a particular focus on developmental aspects of the nervous system.
Diabetes & Cancer Discovery Science
Led by Joyce Niland, Ph.D., the Department of Diabetes & Cancer Discovery Science within the Diabetes & Metabolism Research Institute provides leading-edge research to support advances in diabetes, metabolism and oncology research.
Diabetes Complications & Metabolism
The Department of Diabetes Complications & Metabolism, directed by Rama Natarajan, Ph.D., is at the forefront of research on the complications of diabetes and was the first to study epigenetic changes in diabetic complications.
The Department of Diabetes Immunology, headed by Bart O. Roep, Ph.D., is dedicated to studying immune system mechanisms and their impact on diabetes development and control — particularly type 1 diabetes.
Hematologic Malignancies Translational Science
By improving the understanding of leukemia stem cells, researchers are working at developing cures for leukemia and other hematologic malignancies.
Consisting of several divisions, the Department of Information Sciences enables collaboration in clinical and basic science research throughout the Medical Center and Beckman Research Institute, including study design, data quality and training, and computational statistical analysis.
Pioneering work that’s harnessing the power of the human immune system, resulting in more powerful, less toxic cures for patients.
Our Lymphoma Specialized Program of Research Excellence (SPORE) is developing translational studies to improve the detection and therapy of Hodgkin's and non-Hodgkin's Lymphoma.
Molecular and Cellular Biology
The Department of Molecular and Cellular Biology studies an array of biological systems and problems, focusing on the mechanisms regulating expression of genetic information at both the transcriptional level and the post-transcriptional level.
Molecular & Cellular Endocrinology
The Department of Molecular & Cellular Endocrinology, headed by Debbie C. Thurmond, Ph.D., is pioneering efforts to investigate biological mechanisms involved with type 1 and type 2 diabetes development and substances that promote or interfere with those processes.
Scientist here are investigating the mechanisms underlying cancer and other diseases to develop novel molecular therapeutics.
Researchers across multiple divisions are targeting what causes cancer, how to prevent people from getting cancer, and how to improve the quality of life of cancer survivors.
Translational Research & Cellular Therapeutics
Led by Fouad Kandeel, M.D., Ph.D., this department focuses on stem cell biology and development, translational immunology, islet imaging, isolation and distribution, islet quality assessment and new drug discoveries to improve diabetes treatment and management.
The Wanek Family Project for Type 1 Diabetes
Scientists at The Wanek Family Project for Type 1 Diabetes are creating powerful new approaches to treating type 1 diabetes that will move beyond just managing the disease to curing it.